SEC Form 4 · accession 0001179110-16-028579
ABIOMED INC · ABMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paul Thomas
Director
Period of report
Aug 9, 2016
Accepted (ET)
Aug 11, 2016 · 4:37 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000815094
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $.01 par valueF3 | Aug 9, 2016 | A | 1,621 | $0.00 | A | 22,932 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option (right to buy)F1,F2 | $18.94 | Aug 1, 2016 | M | 10,000 | D | Jan 29, 2014 | May 26, 2020 | Common Stock | 10,000 | 0 | D |
Explanation of responses
- F1Grant to reporting person of this option to buy the number of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2008 Stock Incentive Plan.
- F2These options become exerciseable as following: 50% on the date shown in Table II, Column 6, and 50% on January 29, 2015.
- F3Represents shares underlying the grant of restricted stock units that are to be settled in common stock upon vesting. The restricted stock units will vest in full on the later of: (a) August 9, 2017; or (b) the date of the Issuer's next annual meeting of stockholders.